基于药物信息学的查和构建一个中和的抗SARS-CoV-2 camelidae nanobody药物合物
Elora Kalita1, Mamta Panda2, Sarthak Dhar3
1Life Science Research Centre, Faculty of Science, University of Ostrava, Ostrava, Czechia.
Molecular diversity
|January 28, 2025
概括
这项研究设计了一种针对SARS-CoV-2及其变体的新型双巴拉托普纳米体. 计算分析预测了潜在的COVID-19治疗药物的增强的结合亲和力和有利的物理化学特性.
科学领域:
- 生物技术是生物技术.
- 结构生物学 结构生物学
- 免疫学 免疫学 免疫学
背景情况:
- 来自Camelidae的纳米体 (VHH) 与传统抗体相比,具有更高的稳定性和较低的免疫性.
- 它们的小尺寸和高亲和力使它们适合下一代生物.
- 开发有效的SARS-CoV-2治疗方法仍然是全球卫生优先事项.
研究的目的:
- 设计并通过计算验证一种针对SARS-CoV-2的双巴拉托普纳米体药物联合体.
- 增强纳米体对抗SARS-CoV-2及其变种的结合亲和力和物理化学特性.
主要方法:
- 对SAbDab-nano数据库进行选,以寻找具有所需属性的纳米体.
- 使用分子对接,计算建模,in silico位点导向突变发生和MD模拟.
- 通过生物信息学分析评估结构的物理化学性质,结构完整性和结合效率.
主要成果:
- 一个三重突变纳米体 (N78Q K116N T123F) 与野生类型相比,显示出对SARS-CoV-2 WT RBD,NRP1和Omicron RBD的增强结合亲和力.
- 在中评估预测了高溶解度,热稳定性 (Tm 67.4°C),低分子量 (29.36 KDa) 和无毒,无过敏性质.
- 双巴拉托普纳米体结构显示,对所有测试目标的结合效率有所提高.
结论:
- 双型纳米体的计算设计为开发SARS-CoV-2治疗方法提供了一个有前途的战略.
- 开发的纳米体表现出优越的结合性和有利的特性,可用于潜在的预防性应用.
- 这种方法为传统的COVID-19治疗提供了可行的替代方案.
相关概念视频
02:50Conjugated Proteins
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...